Citation noticeOur citation system is being overhauled
References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.
PMA
PMA is a potent hallucinogen1 with psychedelic properties in the substituted amphetamine class.2 It is found as an adulterant in tablets sold as MDMA3, although its effects differ and do not reliably resemble an entactogenic experience. PMA can cause life-threatening overheating and serotonin syndrome even at moderate doses. PMA sold as ecstasy in pill or capsule form is usually indistinguishable from ecstasy.4
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Duration
Subjective Effects
Reagent Testing
Expected colorimetric results for common reagent tests. Colors show reaction change over 1–2 minutes.
Pharmacology
Pharmacodynamics
PMA promotes serotonin release and inhibits serotonin reuptake5, with evidence suggesting that reuptake inhibition may be more prominent than its releasing action. It also potently inhibits monoamine oxidase A (MAO-A)6, with no significant effect on MAO-B. Its effects on dopamine and norepinephrine transporters are weak, and rodent studies show a robust increase in brain serotonin but only a small increase in dopamine. PMA has very low affinity for 5-HT1A, 5-HT2A, and 5-HT2C receptors, but substantially higher affinity for mouse and rat TAAR1.7
Pharmacokinetics
Human studies detected unchanged PMA in urine after administration, demonstrating that some of the substance is excreted without being metabolized.
Dangerous
Highest riskThese combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
Tolerance
Harm Potential
Toxicity
PMA can cause potentially fatal increases in temperature and blood pressure at 60–80 mg, and overdose may occur only slightly above the usual recreational dose range. Susceptibility varies substantially between individuals; a dose causing mild effects in one person may be fatal in another. Severe hyperthermia is the most common cause of PMA-related death.8
PMA ingestion can cause severe tachycardia, irregular heartbeat, and hypertension; doses as low as 60 mg can produce substantial increases in pulse and blood pressure.
PMA can cause life-threatening hyperthermia and serotonin syndrome even at moderate doses, with severe hyperthermia also occurring during overdose.
Severe hypoglycaemia accompanied by hyperkalaemia was reported in two patients with confirmed PMA poisoning.9
PMA overdose can sometimes cause rhabdomyolysis.10
PMA overdose can sometimes cause cerebral hemorrhage requiring emergency surgery.
PMA can cause labored breathing.
Seizure Risk
PMA ingestion has been associated with seizures, and convulsions are a characteristic feature of overdose.
History & Culture
Legality
International
PMA (1-(4-methoxyphenyl)propan-2-amine) is internationally controlled in Schedule I of the Convention on Psychotropic Substances of 1971.
By Country
References
Source Pages
Citations
Further Reading
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed: this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the PMA article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.